Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 31 min 6 sec ago

TrueBlue Reports Fourth Quarter and Full-Year 2024 Results

Wed, 02/19/2025 - 18:47
TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE:TBI) today announced its fourth quarter and full-year results for 2024. Fourth Quarter 2024 Financial Highlights Revenue of $386 million compared to $492 million in the prior year period Fiscal fourth quarter for 2024 consisted of 13 weeks versus 14 weeks in the fiscal fourth quarter of 2023 Revenue decreased 16 percent on a comparable 13-week basis Net loss of $12 million compared to net loss of $3 million in the prior year period SG&A expense

Rocky Brands, Inc. to Report Fourth Quarter and Full Year 2024 Results on February 25, 2025

Wed, 02/19/2025 - 18:47
NELSONVILLE, Ohio--(BUSINESS WIRE)--Rocky Brands, Inc. (NASDAQ: RCKY) today announced that the company will release its financial results for the fourth quarter and year ended December 31, 2024, after the market close on Tuesday, February 25, 2025. Management will host a conference call that afternoon (February 25, 2025) at 4:30 p.m. ET to discuss the financial results. Investors and analysts interested in participating in the call are invited to dial (877) 704-4453 (domestic) or (201) 389-0920

Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference

Wed, 02/19/2025 - 18:47
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4 at 8:50 a.m. PT / 11:50 a.m. ET in Boston, Massachusetts. A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days. About Vir Biotech

Amplitude Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Wed, 02/19/2025 - 18:47
SAN FRANCISCO--(BUSINESS WIRE)--Amplitude, Inc. (Nasdaq: AMPL), the leading digital analytics platform, today announced financial results for its fourth quarter and fiscal year ended December 31, 2024. "Amplitude closed 2024 strong. Our platform strategy is resonating with customers, and we're making great progress with enterprises," said Spenser Skates, CEO and co-founder of Amplitude. "Every company needs three things: data they can trust, an understanding of what customers are doing in the p

Klaviyo Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Wed, 02/19/2025 - 18:47
BOSTON--(BUSINESS WIRE)--Klaviyo (NYSE: KVYO), the company that powers smarter digital relationships, today announced results for its fourth quarter and fiscal year ended December 31, 2024. “We had a very strong finish to the year, crossing a $1 billion revenue run rate as we delivered our strongest Black Friday Cyber Monday yet. Our performance in 2024 highlights the critical role our intelligent, flexible data platform plays in driving growth for our more than 167,000 customers,” said Andrew

NerdWallet Reports Fourth Quarter and Full Year 2024 Results

Wed, 02/19/2025 - 18:47
SAN FRANCISCO--(BUSINESS WIRE)--NERDWALLET REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

ServisFirst Bank Announces New Chief Financial Officer

Wed, 02/19/2025 - 18:47
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NYSE:SFBS), is pleased to announce the hiring of David Sparacio as Chief Financial Officer, following an extensive nationwide search by Chartwell Partners. A seasoned financial executive with over three decades of experience in banking and financial management, Sparacio will oversee the Bank’s financial strategy, regulatory reporting, and accounting operations. Sparacio will assume the role on March 10,

ALAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alarum Technologies Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Wed, 02/19/2025 - 18:47
NEW YORK--(BUSINESS WIRE)---- $ALAR #ALAR--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Alarum Technologies Ltd. (“Alarum” or “the Company”) (NASDAQ: ALAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Alarum

FMC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FMC Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Wed, 02/19/2025 - 18:47
NEW YORK--(BUSINESS WIRE)---- $FMC #ClassAction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FMC Corporation (“FMC” or “the Company”) (NYSE: FMC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired FMC securities betwee

BBVA Argentina Announces Fourth Quarter and Fiscal Year 2024 Financial Results Schedule

Wed, 02/19/2025 - 18:47
BUENOS AIRES, Argentina--(BUSINESS WIRE)--Banco BBVA Argentina S.A. (NYSE; BYMA; MAE: BBAR; LATIBEX: XBBAR) today announced that it will report its Fourth Quarter & Fiscal Year 2024 results on Wednesday, March 5, 2025. Earnings Release Wednesday, March 5, 2025 Time: After market close Conference Call Thursday, March 6, 2025 Time: 12:00 p.m. Buenos Aires time – (10:00 a.m. EST) Quiet Period From Wednesday, February 19, though Wednesday, March 5, 2025 Executives Ms. Carmen Morillo Arroyo, Chi

KBRA Assigns Preliminary Ratings to GCAT 2025-INV1 Trust

Wed, 02/19/2025 - 15:47
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to 59 classes of mortgage-backed notes from GCAT 2025-INV1 Trust. The GCAT 2025-INV1 mortgage loans are secured by first liens on non-owner occupied (NOO) investor properties and second homes. The loans were primarily underwritten to agency guidelines. The pool comprises 1,075, first-lien, fixed rate residential mortgage loans as of the cut-off date. The pool is characterized by moderate borrower equity in each mortgaged property, as e

SBSB Eastham Celebrates 10th Anniversary, a Decade of Success and Growth

Wed, 02/19/2025 - 15:47
HOUSTON--(BUSINESS WIRE)--Schouest, Bamdas, Soshea, BenMaier & Eastham PLLC (SBSB Eastham) is proud to celebrate its 10th anniversary, a decade marked by success, extraordinary growth and an unwavering commitment to providing exceptional service and results for its clients. Founded on Feb. 19, 2015 as SBSB Law by attorneys John Schouest, Robert Bamdas, Brad Soshea and Limor BenMaier, SBSB Eastham began with 18 attorneys handling cases from Houston, Boca Raton, Fla., and Chicago. Today, the

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of DHI Group, Inc. (NYSE: DHX) and Encourages Long-Term Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating DHI Group, Inc. (NYSE: DHX) (“DHI”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/dhi-group/ Since January 2023, shares of DHI’s common stock have declined in value from a trading price of over $6.00 per share to a current trading price of below $3.00 per share, a decline of over 50% in value. The investigation seeks to determine whether DHI and/or the

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Amicus Therapeutics, Inc. (NASDAQ: FOLD) (“Amicus”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/amicus-therapeutics/ Since December 2023, shares of Amicus’ common stock have declined in value from a trading price of $14.50 per share to a current trading price of approximately $11.00 per share, a decline of nearly 25% in value. The investigation seeks

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Darling Ingredients Inc. (NYSE: DAR) and Encourages Long-Term Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Darling Ingredients Inc. (NYSE: DAR) (“Darling”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/cases/darling-ingredients/ Since July 2023, shares of Darling’s common stock have declined in value from a trading price of over $70.00 per share to a current trading price of below $40.00 per share, a decline of over 42% in value. The investigation seeks to determ

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of National HealthCare Corporation (NYSE: NHC) and Encourages Long-Term Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating National HealthCare Corporation (NYSE: NHC) (“NHC”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/cases/national-healthcare-corp/ Since November 2024, shares of NHC’s common stock have declined in value from a trading price of over $135.00 per share to a current trading price of below $100.00 per share, a decline of 26% in value. The investigation seeks to d

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Semler Scientific, Inc. (NASDAQ: SMLR) and Encourages Long-Term Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Semler Scientific, Inc. (“Semler”) (NASDAQ: SMLR) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/semler-scientific/ The investigation seeks to determine whether Semler and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors in connection with recent corporate actions. Semler s

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of RPM International Inc. (NYSE: RPM) and Encourages Shareholders to Contact the Firm

Wed, 02/19/2025 - 15:47
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating RPM International Inc. (NYSE: RPM) (“RPM”) on behalf of the company’s shareholders. Click here for additional information: https://kaskelalaw.com/case/rpm-international/ Since November 2024, shares of RPM’s common stock have declined in value from a trading price of over $140.00 per share to a current trading price of below $125.00 per share, a decline of over 10% in value. The investigation seeks to determine whe

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Edison International Investors – EIX

Wed, 02/19/2025 - 15:47
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Edison International (NYSE: EIX) between February 25, 2021 and February 6, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Edison investors under the federal securities laws. To join the Edison class action, go to https://rosenlegal.com/submit-form/?case_id=33590 or call Phillip Kim, Esq

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Final Results of Quarterly Tender Offer

Wed, 02/19/2025 - 15:47
NEW YORK--(BUSINESS WIRE)--BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (the "Fund") today announced the final results of its quarterly tender offer (the "Tender Offer") for up to 2.5% of the Fund's issued and outstanding shares of common stock (the "Shares"). The Tender Offer, which expired at 5:00 p.m. Eastern time on February 18, 2025, was oversubscribed. Therefore, in accordance with the terms and conditions of the Tender Offer, the Fund will purchase Shares from all tenderin

Pages